This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Allscripts (MDRX) Up 13.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Allscripts (MDRX) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allscripts, Elligo Health Enter in Strategic Partnership
by Zacks Equity Research
Allscripts' (MDRX) Strategic Partnership with Elligo Health would aid the company in capturing the Clinical Research Organizations' lucrative market.
Allscripts (MDRX) Meets Q2 Earnings Estimates, View Upbeat
by Zacks Equity Research
Allscripts' (MDRX) stellar bookings growth was the key highlight of the second quarter. A solid guidance for full-year 2017, and a strong long-term outlook instill investor confidence.
Bear of the Day: athenahealth (ATHN)
by Kevin Cook
Billionaire Paul Singer of the Elliot hedge funds was troubled by the earnings decline too and he's making a big bet to fix it
Allscripts (MDRX) Beats on Q1 Earnings, Revenues In Line
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX) reported first-quarter 2017 earnings of 10 cents per share, beating the Zacks Consensus Estimate by a penny.
Zacks Podcast Highlights: Should Investors Forget the Obamacare Battle and Focus on HealthTech Stocks Instead?
by Eric Dutram
Although changes might be coming to the world of health care, this industry could be the spot for investors to focus on regardless of what Washington decides.
Health Care and Technology: A Perfect Combo for Stock Investors Now?
by Eric Dutram
Although changes might be coming to the world of health care, this industry could be the spot for investors to focus on regardless of what Washington decides.
Allscripts' (MDRX) dbMotion Solution Available Through Azure
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX), announced that dbMotion Solution will be now available through Microsoft Corporation's (MSFT) cloud computing service Azure.
Allscripts Healthcare Solutions (MDRX) Jumps: Stock Rises 7%
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX) moved big last session, as its shares jumped a little over 7% on the day.
Allscripts (MDRX) Acknowledged by LPP's CDIS Framework
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.